Younger women are being diagnosed with breast cancer more often than screening guidelines anticipate. Many of these cancers ...

From low-carb to probiotics, craft beers are going all out to create novel, functional options that can attract a whole new ...

A study of data from seven outpatient facilities in the New York region found that 20–24% of all the breast cancers diagnosed ...

Samsung Bioepis Co., Ltd. today announced the launch of OBODENCEtm (60 mg pre-filled syringe) and XBRYKtm (120 mg vial), denosumab biosimilars referencing Prolia and Xgeva. The products will be ...

Carpets, sofas, cars – these are all places we spend a lot of time, and if the fabric we are in contact with has been treated with PFAS, this represents an opportunity for exposure. People can be ...

Younger women face a persistent, underestimated breast cancer risk that demands earlier and more tailored screening.

A study of data from seven outpatient facilities in the New York region found that 20-24% of all the breast cancers diagnosed during an 11-year period were found in women age 18 to 49, according to ...

The reforms mark a significant advance in bodily autonomy for people born with variations in sex characteristics (IVSCs).

OBODENCE (60 mg pre-filled syringe) and XBRYK (120 mg vial) become available across Europe as of December 2025 and January 2026, respectively Marks Samsung Bioepis' 10th and 11th biosimilars ...